Chemotherapy-induced Alopecia Treatment Device Market 2030 Forecast, Future Outlook, Share, Trends, Application
The global chemotherapy-induced alopecia (CIA) treatment device market size was valued at USD 67.3 million in 2023 and is forecasted to reach USD 174.7 million by 2030, expanding at a robust CAGR of 14.6% from 2024 to 2030. Chemotherapy-induced alopecia refers to hair loss that occurs as a side effect of chemotherapy drugs, which target rapidly dividing cells in the body, including those in hair follicles. To address this, specialized CIA treatment devices most notably scalp cooling systems are used to prevent or minimize hair loss during treatment. These devices work by lowering the scalp’s temperature, which reduces blood flow to hair follicles, thereby decreasing the concentration of chemotherapy drugs that reach them. This cooling effect helps in preserving hair and improving patients’ emotional well-being and quality of life during cancer treatment. The market is witnessing strong growth due to several interrelated factors. A key driver is the global rise in ca...